Evaluation of Psilocybin (TRP-8802) in the Treatment of Binge Eating Disorder

计划入组 5 人 · 首次发布于 2021 年 9 月 5 日

Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS)

计划入组 14 人 · 首次发布于 2024 年 1 月 16 日

EMDR on Pain in Patients With in Patients Rheumatoid Arthritis

计划入组 64 人 · 首次发布于 2023 年 7 月 13 日

TRYP-0082

thalassemia therapeutics

PGTI-0306 based therapeutics (Phenogene Therapeutics)

Tryp Therapeutics, Inc.

Canada

JASPER THERAPEUTICS, INC

United States

CRISPR Therapeutics, Inc.

United States

Former J&J Executive Herwig Janssen Appointed Chairman of Tryptamine Therapeutics as Company Advances Psilocin-Based Clinical Programs

Tryptamine Therapeutics Partners with Imperial College to Develop EEG-Based Biomarker for Precision Psychedelic Therapy

New Mexico Accelerates Psilocybin Therapy Program Launch to December 2026, New Jersey Approves Hospital-Based Pilot